healthcare
healthcare Articles
Altimmune made some progress with its COVID-19 treatment on Monday after it announced some new funding for its trials.
Published:
Last Updated:
More investors now consider waste removal and cleaning company BioHiTech Global to be among those on the growing list of COVID-19 stocks. Thus, its shares more than doubled to start out the week.
Published:
Gilead has priced its COVID-19 drug candidate at $2,340 for a five-day treatment in the United States and some other developed countries. The company set the price for a single vial of remdesivir at...
Published:
Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment of fibrosis due to nonalcoholoic steatohepatitis.
Published:
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
The FDA has notified Fulcrum Therapeutics that it is allowed to proceed with initiating its Phase 3 trial of losmapimod in higher risk hospitalized adults with COVID-19.
Published:
GW Pharmaceuticals took a big step forward for the development of its cannabidiol product in the United Kingdom.
Published:
A labeling requirement in California warning consumers of the risks of products derived from cannabis could have a chilling effect on the state's legal growers and retailers.
Published:
Inovio Pharmaceuticals has announced that it received $71 million in funding from the U.S. Department of Defense to support the production of its delivery device for the COVID-19 vaccine.
Published:
Sanofi and Translate Bio are making waves in the fight against the novel coronavirus as the two have agreed to expand their existing 2018 collaboration and license agreement
Published:
Sintx Technologies shares nearly tripled after the company announced a big win against the coronavirus in a controlled laboratory study.
Published:
Evoke Pharma says the FDA has approved its New Drug Application for Gimoti nasal spray for symptom relief in adults with acute and recurrent diabetic gastroparesis.
Published:
1Life Healthcare is known for its One Medical service, which is effectively a membership-based primary care model. One analyst called it "a next-generation primary care provider."
Published:
The announcement that AnPac Bio-Medical Science has entered into a three-year strategic cancer screening collaboration contract with Beijing Yuan Jian Health Management in China lit a fire under the...
Published:
Selecta Biosciences and Sarepta Therapeutics have announced that they had entered into a research license and option agreement.
Published: